220 related articles for article (PubMed ID: 23769565)
21. Clonal spread and azole-resistant mechanisms of non-susceptible Candida albicans isolates from vulvovaginal candidiasis patients in three Shanghai maternity hospitals.
Wu Y; Li C; Wang Z; Gao J; Tang Z; Chen H; Ying C
Med Mycol; 2018 Aug; 56(6):687-694. PubMed ID: 29136186
[TBL] [Abstract][Full Text] [Related]
22. Resistance mechanisms in clinical isolates of Candida albicans.
White TC; Holleman S; Dy F; Mirels LF; Stevens DA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1704-13. PubMed ID: 12019079
[TBL] [Abstract][Full Text] [Related]
23. Cloning of Candida albicans genes conferring resistance to azole antifungal agents: characterization of CDR2, a new multidrug ABC transporter gene.
Sanglard D; Ischer F; Monod M; Bille J
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():405-416. PubMed ID: 9043118
[TBL] [Abstract][Full Text] [Related]
24. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
[TBL] [Abstract][Full Text] [Related]
25. Azole resistance in Candida albicans from animals: Highlights on efflux pump activity and gene overexpression.
Rocha MFG; Bandeira SP; de Alencar LP; Melo LM; Sales JA; Paiva MAN; Teixeira CEC; Castelo-Branco DSCM; Pereira-Neto WA; Cordeiro RA; Sidrim JJC; Brilhante RSN
Mycoses; 2017 Jul; 60(7):462-468. PubMed ID: 28295690
[TBL] [Abstract][Full Text] [Related]
26. Overexpression and mutation as a genetic mechanism of fluconazole resistance in Candida albicans isolated from human immunodeficiency virus patients in Indonesia.
Rosana Y; Yasmon A; Lestari DC
J Med Microbiol; 2015 Sep; 64(9):1046-1052. PubMed ID: 26297039
[TBL] [Abstract][Full Text] [Related]
27. [Function and gene expression of the active efflux transporters in drug-resistant Candida albicans].
Guo HJ; Xia ZD; Wu GL; Zhou H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Feb; 32(1):183-7. PubMed ID: 17344615
[TBL] [Abstract][Full Text] [Related]
28. Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of
Černáková L; Dižová S; Gášková D; Jančíková I; Bujdáková H
Microb Drug Resist; 2019; 25(6):805-812. PubMed ID: 30785845
[No Abstract] [Full Text] [Related]
29. Molecular mechanism of azoles resistant Candida albicans in a patient with chronic mucocutaneous candidiasis.
Zhang MR; Zhao F; Wang S; Lv S; Mou Y; Yao CL; Zhou Y; Li FQ
BMC Infect Dis; 2020 Feb; 20(1):126. PubMed ID: 32046674
[TBL] [Abstract][Full Text] [Related]
30. Transcription initiation of genes associated with azole resistance in Candida albicans.
Harry JB; Song JL; Lyons CN; White TC
Med Mycol; 2002 Feb; 40(1):73-81. PubMed ID: 11860016
[TBL] [Abstract][Full Text] [Related]
31. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
32. Doxorubicin induces drug efflux pumps in Candida albicans.
Kofla G; Turner V; Schulz B; Storch U; Froelich D; Rognon B; Coste AT; Sanglard D; Ruhnke M
Med Mycol; 2011 Feb; 49(2):132-42. PubMed ID: 20818920
[TBL] [Abstract][Full Text] [Related]
33. Antifungal Effects of Voriconazole-Loaded Nano-Liposome on Fluconazole
Hassanpour P; Hamishehkar H; Bahari Baroughi B; Baradaran B; Sandoghchian Shotorbani S; Mohammadi M; Shomali N; Aghebati-Maleki L; Nami S
Assay Drug Dev Technol; 2021 Oct; 19(7):453-462. PubMed ID: 34435891
[No Abstract] [Full Text] [Related]
34. Overexpression of Candida albicans CDR1, CDR2, or MDR1 does not produce significant changes in echinocandin susceptibility.
Niimi K; Maki K; Ikeda F; Holmes AR; Lamping E; Niimi M; Monk BC; Cannon RD
Antimicrob Agents Chemother; 2006 Apr; 50(4):1148-55. PubMed ID: 16569823
[TBL] [Abstract][Full Text] [Related]
35. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Tsao S; Rahkhoodaee F; Raymond M
Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
[TBL] [Abstract][Full Text] [Related]
36. Involvement of mitochondrial aerobic respiratory activity in efflux-mediated resistance of C. albicans to fluconazole.
Guo H; Xie SM; Li SX; Song YJ; Zhong XY; Zhang H
J Mycol Med; 2017 Sep; 27(3):339-344. PubMed ID: 28483448
[TBL] [Abstract][Full Text] [Related]
37. The roles of CDR1, CDR2, and MDR1 in kaempferol-induced suppression with fluconazole-resistant Candida albicans.
Shao J; Zhang M; Wang T; Li Y; Wang C
Pharm Biol; 2016; 54(6):984-92. PubMed ID: 26459663
[TBL] [Abstract][Full Text] [Related]
38. [Characterization of azole resistance mechanisms in Chilean clinical isolates of Candida albicans].
Fuentes M; Hermosilla G; Alburquenque C; Falconer MA; Amaro J; Tapia C
Rev Chilena Infectol; 2014 Oct; 31(5):511-7. PubMed ID: 25491448
[TBL] [Abstract][Full Text] [Related]
39. Up-regulation of CDR1 and MDR1 efflux pump genes and fluconazole resistance are involved in recurrence in Candida albicans-induced vulvovaginal candidiasis.
Esfahani A; Omran AN; Salehi Z; Shams-Ghahfarokhi M; Ghane M; Eybpoosh S; Razzaghi-Abyaneh M
Diagn Microbiol Infect Dis; 2024 May; 109(1):116242. PubMed ID: 38452558
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of berberine-mediated fluconazole-susceptibility enhancement in clinical fluconazole-resistant Candida tropicalis isolates.
Shi G; Shao J; Wang T; Wu D; Wang C
Biomed Pharmacother; 2017 Sep; 93():709-712. PubMed ID: 28700974
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
